Competition law and policy in the Japanese pharmaceutical sector / / edited by Akira Negishi, Masako Wakui and Naoko Mariyama

• Record Nr.: UNINA9910743354903321
• Pubbl/distr/stampa: Gateway East, Singapore : , : Springer, , [2022]; ©2022
• ISBN: 981-16-7813-8; 981-16-7814-6
• Descrizione fisica: 1 online resource (xxi, 245 pages)
• Collana: Kobe University monograph series in social science research
• Disciplina: 343.520721
• Soggetti: Pharmaceutical industry; Drugs - Law and legislation; Antitrust law
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: Regulation and Competition in the Pharmaceutical Industry in Japan -- Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population -- Drug Regulation in Japan -- Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan -- Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies Gift-giving Practices -- Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan -- Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act -- Merger Regulations in the Japanese Pharmaceutical Industry -- Pay-for-delay Agreements in Japan -- No Challenge Clauses in the Pharmaceutical Industry in Japan -- Will Authorised Biologics deter Biosimilars? -Utilising JFTCs expertise in drug pricing -- The Pharmaceutical Industry in Japan: A History of Its Development -- Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.
• Sommario/riassunto: "The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and ; discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States"--Publisher's description.